Bile acid metabolome after an oral lipid tolerance test by liquid chromatography-tandem mass spectrometry (LC-MS/MS)

PLoS ONE

Volumn 11, Issue 2, 2016, Pages

  Schmid, Andreas ^a   Neumann, Hannah ^a   Karrasch, Thomas ^a   Liebisch, Gerhard ^b   Schäffler, Andreas ^a  

^a UNIVERSITY HOSPITAL GIESSEN   (Germany)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; BILE ACID CONJUGATE; CHENODEOXYCHOLIC ACID; CHOLIC ACID; DEOXYCHOLIC ACID; FIBROBLAST GROWTH FACTOR 19; GLYCOCHENODEOXYCHOLIC ACID; GLYCOCHOLIC ACID; GLYCODEOXYCHOLIC ACID; GLYCOLITHOCHOLIC ACID; HYODEOXYCHOLIC ACID; LITHOCHOLIC ACID; TAURINE; TAUROCHENODEOXYCHOLIC ACID; TAUROCHOLIC ACID; TAURODEOXYCHOLIC ACID; TAUROLITHOCHOLIC ACID; TAUROURSODEOXYCHOLIC ACID; URSODEOXYCHOLIC ACID; FAT INTAKE; FGF19 PROTEIN, HUMAN; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 21; GLYCINE; ORAL CONTRACEPTIVE AGENT; TRIACYLGLYCEROL; VEGETABLE OIL;

ADULT; ANTHROPOMETRY; ARTICLE; BILE ACID SYNTHESIS; BLOOD SAMPLING; COHORT ANALYSIS; CONTROLLED STUDY; FAT TOLERANCE TEST; FEEDBACK SYSTEM; FEMALE; HUMAN; HUMAN EXPERIMENT; LABORATORY TEST; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; METABOLOME; NORMAL HUMAN; ADMINISTRATION AND DOSAGE; ADOLESCENT; BLOOD; CHEMISTRY; COMPARATIVE STUDY; DRUG EFFECTS; FAT INTAKE; MIDDLE AGED; OBESITY; PHARMACOLOGY; PHYSIOLOGY; POSTPRANDIAL STATE; PROCEDURES; TANDEM MASS SPECTROMETRY;

ADOLESCENT; ADULT; ANTHROPOMETRY; BILE ACIDS AND SALTS; CHROMATOGRAPHY, LIQUID; CONTRACEPTIVES, ORAL, HORMONAL; DIETARY FATS; FEMALE; FIBROBLAST GROWTH FACTORS; GLYCINE; HUMANS; MALE; METABOLOME; MIDDLE AGED; OBESITY; PLANT OILS; POSTPRANDIAL PERIOD; TANDEM MASS SPECTROMETRY; TAURINE; TRIGLYCERIDES;

EID: 84959377684     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0148869     Document Type: Article

References (26)

1. Fiorucci S, Cipriani S, Baldelli F, Mencarelli A. Bile acid-activated receptors in the treatment of dyslipidemia and related disorders. Progress in lipid research. 2010; 49(2):171-85. doi: 10.1016/j.plipres. 2009.11.001 PMID: 19932133.
2. Fiorucci S, Cipriani S, Mencarelli A, Renga B, Distrutti E, Baldelli F. Counter-regulatory role of bile acid activated receptors in immunity and inflammation. Current molecular medicine. 2010; 10(6):579-95. PMID: 20642438.
3. Fiorucci S, Mencarelli A, Distrutti E, Palladino G, Cipriani S. Targetting farnesoid-X-receptor: from medicinal chemistry to disease treatment. Curr Med Chem. 2010; 17(2):139-59. PMID: 19941473.
4. Prawitt J, Staels B. Bile acid sequestrants: glucose-lowering mechanisms. Metabolic syndrome and related disorders. 2010; 8 Suppl 1:S3-8. doi: 10.1089/met.2010.0096 PMID: 20977365.
5. Stroeve JH, Brufau G, Stellaard F, Gonzalez FJ, Staels B, Kuipers F. Intestinal FXR-mediated FGF15 production contributes to diurnal control of hepatic bile acid synthesis in mice. Laboratory investigation; a journal of technical methods and pathology. 2010; 90(10):1457-67. doi: 10.1038/labinvest.2010.107 PMID: 20531290.
6. Staels B, Handelsman Y, Fonseca V. Bile acid sequestrants for lipid and glucose control. Current diabetes reports. 2010; 10(1):70-7. doi: 10.1007/s11892-009-0087-5 PMID: 20425070; PubMed Central PMCID: PMC2821506.
7. Holt JA, Luo G, Billin AN, Bisi J, McNeill YY, Kozarsky KF, et al. Definition of a novel growth factordependent signal cascade for the suppression of bile acid biosynthesis. Genes & development. 2003; 17(13):1581-91. doi: 10.1101/gad.1083503 PMID: 12815072; PubMed Central PMCID: PMC196131.
8. Angelin B, Larsson TE, Rudling M. Circulating fibroblast growth factors as metabolic regulators - a critical appraisal. Cell metabolism. 2012; 16(6):693-705. doi: 10.1016/j.cmet.2012.11.001 PMID: 23217254.
9. Kharitonenkov A. FGFs and metabolism. Current opinion in pharmacology. 2009; 9(6):805-10. doi: 10.1016/j.coph.2009.07.001 PMID: 19683963.
10. Cicione C, Degirolamo C, Moschetta A. Emerging role of fibroblast growth factors 15/19 and 21 as metabolic integrators in the liver. Hepatology. 2012; 56(6):2404-11. doi: 10.1002/hep.25929 PMID: 22753116.
11. Kurosu H, Choi M, Ogawa Y, Dickson AS, Goetz R, Eliseenkova AV, et al. Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21. The Journal of biological chemistry. 2007; 282(37):26687-95. doi: 10.1074/jbc. M704165200 PMID: 17623664; PubMed Central PMCID: PMC2496965.
12. Beenken A, Mohammadi M. The FGF family: biology, pathophysiology and therapy. Nature reviews Drug discovery. 2009; 8(3):235-53. doi: 10.1038/nrd2792 PMID: 19247306; PubMed Central PMCID: PMC3684054.
13. Jones S. Mini-review: endocrine actions of fibroblast growth factor 19. Molecular pharmaceutics. 2008; 5(1):42-8. doi: 10.1021/mp700105z PMID: 18179175.
14. Inagaki T, Choi M, Moschetta A, Peng L, Cummins CL, McDonald JG, et al. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell metabolism. 2005; 2 (4):217-25. doi: 10.1016/j.cmet.2005.09.001 PMID: 16213224.
15. Goodwin B, Jones SA, Price RR, Watson MA, McKee DD, Moore LB, et al. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Molecular cell. 2000; 6 (3):517-26. PMID: 11030332.
16. Cyphert HA, Ge X, Kohan AB, Salati LM, Zhang Y, Hillgartner FB. Activation of the farnesoid X receptor induces hepatic expression and secretion of fibroblast growth factor 21. The Journal of biological chemistry. 2012; 287(30):25123-38. doi: 10.1074/jbc.M112.375907 PMID: 22661717; PubMed Central PMCID: PMC3408207.
17. Adorini L, Pruzanski M, Shapiro D. Farnesoid X receptor targeting to treat nonalcoholic steatohepatitis. Drug discovery today. 2012; 17(17-18):988-97. doi: 10.1016/j.drudis.2012.05.012 PMID: 22652341.
18. Matysik S, Martin J, Bala M, Scherer M, Schaffler A, Schmitz G. Bile acid signaling after an oral glucose tolerance test. Chemistry and physics of lipids. 2011; 164(6):525-9. doi: 10.1016/j.chemphyslip.2011. 05.003 PMID: 21679700.
19. Karrasch T, Leszczak S, Bala M, Ober I, Martin J, Schmid A, et al. Short-term regulation of Visfatin release in vivo by oral lipid ingestion and in vitro by fatty acid stimulation. Exp Clin Endocrinol Diabetes. 2014; 122(2):126-34. doi: 10.1055/s-0033-1363262 PMID: 24554513.
20. Schmid A, Leszczak S, Ober I, Karrasch T, Schaffler A. Short-term and divergent regulation of FGF-19 and FGF-21 during oral lipid tolerance test but not oral glucose tolerance test. Exp Clin Endocrinol Diabetes. 2015; 123(2):88-94. doi: 10.1055/s-0034-1395635 PMID: 25654672.
21. Scherer M, Gnewuch C, Schmitz G, Liebisch G. Rapid quantification of bile acids and their conjugates in serum by liquid chromatography-tandem mass spectrometry. Journal of chromatography B, Analytical technologies in the biomedical and life sciences. 2009; 877(30):3920-5. doi: 10.1016/j.jchromb. 2009.09.038 PMID: 19819765.
22. Lundasen T, Galman C, Angelin B, Rudling M. Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man. Journal of internal medicine. 2006; 260(6):530-6. doi: 10.1111/j.1365-2796.2006.01731.x PMID: 17116003.
23. Yang L, Feng F, Fawcett JP, Tucker IG. Kinetic and equilibrium studies of bile salt-liposome interactions. Journal of liposome research. 2015; 25(1):58-66. doi: 10.3109/08982104.2014.928888 PMID: 24960448.
24. Schreuder TC, Marsman HA, Lenicek M, van Werven JR, Nederveen AJ, Jansen PL, et al. The hepatic response to FGF19 is impaired in patients with nonalcoholic fatty liver disease and insulin resistance. American journal of physiology Gastrointestinal and liver physiology. 2010; 298(3):G440-5. doi: 10.1152/ajpgi.00322.2009 PMID: 20093562.
25. Zhao X, Peter A, Fritsche J, Elcnerova M, Fritsche A, Haring HU, et al. Changes of the plasma metabolome during an oral glucose tolerance test: is there more than glucose to look at? American journal of physiology Endocrinology and metabolism. 2009; 296(2):E384-93. doi: 10.1152/ajpendo.90748.2008 PMID: 19066319.
26. Shaham O, Wei R, Wang TJ, Ricciardi C, Lewis GD, Vasan RS, et al. Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity. Molecular systems biology. 2008; 4:214. doi: 10.1038/msb.2008.50 PMID: 18682704; PubMed Central PMCID: PMC2538910.